Ventyx Biosciences Overview
Latest ROE for Ventyx Biosciences: -55.71% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-55.71%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Ventyx Biosciences (VTYX) currently reports a ROE of -55.71%. That is below the sector sector average of -5.84%. Use the charts on this page to explore Ventyx Biosciences's ROE history and peer comparisons.
Ventyx Biosciences's ROE of -55.71% is lower than the its sector sector average of -5.84%. That is roughly 853.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Ventyx Biosciences's current -55.71% should be judged against industry norms (sector average: -5.84%) and against VTYX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -55.71%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -5.84%. From there, open related valuation or income-statement pages for Ventyx Biosciences, and consider following VTYX for alerts when major investors trade the stock.
